Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
scientific article (publication date: 20 September 2014)
Author/s
author: Richard F. Kefford, Jeffrey S Weber, Anthony M Joshua, Richard W. Joseph, Bartosz Chmielowski, Adil Daud, Jedd D. Wolchok, Antoni Ribas, F Stephen Hodi, Roxana S. Dronca, Tara C Gangadhar, Michael A Postow, Peter D. Boasberg
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.